BeOne Medicines Earnings
NASDAQ: ONCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 354.47 0.00%
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$2.34
BeOne Medicines earnings summary
BeOne Medicines is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $2.34. In its most recent report on Aug 5, 2026 (Q2 2026), ONC posted EPS of $0.16. Revenue for the quarter was $1.71 billion.
Quarterly EPS is up 166.7% from the same quarter a year earlier. Across the last 16 reports, ONC shares moved an average of 5.8% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
ONC earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $0.16 | — | -0.2% |
| May 6, 2026 | — | $0.15 | — | -6.0% |
| Feb 26, 2026 | — | $0.05 | — | -5.0% |
| Nov 6, 2025 | — | $0.08 | — | +14.3% |
| Aug 6, 2025 | — | $0.06 | — | +11.5% |
| May 7, 2025 | — | $0.00 | — | -1.6% |
| Feb 27, 2025 | — | $-0.10 | — | -9.1% |
| Nov 12, 2024 | — | $-0.09 | — | +0.7% |
| Aug 7, 2024 | — | $-0.09 | — | +6.5% |
| May 8, 2024 | — | $-0.19 | — | +7.3% |
| Feb 26, 2024 | — | $-0.26 | — | -3.9% |
| Nov 9, 2023 | — | $0.15 | — | -6.1% |
| Aug 2, 2023 | — | $-0.28 | — | -2.3% |
| May 4, 2023 | — | $-0.26 | — | -4.6% |
| Feb 27, 2023 | — | $-0.33 | — | -10.4% |
| Nov 9, 2022 | — | $-0.41 | — | +2.6% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.